Keywords: estonia, won, subsidize, glivec, subsidise, glivecestonia, social

Estonia won

Article | 28 April 2003

Estonia won't subsidise GlivecEstonia's Social Ministry has decided not to subsidize the price of Novartis' Glivec/Gleevec (imatinib mesylate) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Gleevec

Imatinib Mesylate

Go to drug listing